QA: Filana Therapeutics INC in us_pharma/2014

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001069530_2015_Filana_Therapeutics_INC.pdf

Logs

Graph

Absolute values for 0001069530, Filana Therapeutics INC

  xvar xval
0 AssetsCurrent 40,829,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 65,000
3 remainder_Assets 12,000
4 LiabilitiesCurrent 850,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,135,416
9 ResearchAndDevelopmentExpense 7,022,296
10 remainder_Expenses -71,302
11 remainder_Revenues 41,128,652
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -1,010
  yvar yval
0 Assets 40,906,000
1 Liabilities 850,000
2 Expenses 12,086,410
3 Revenues 41,128,652
4 StockholdersEquity 40,056,000
5 NetIncome 29,042,242
6 ComprehensiveNetIncome 29,041,737
7 BaseVar 47,486,036
8 EconomicCapitalRatiobeforeLimitedLiability 5.57
9 EconomicCapitalRatio 5.69

Edgar->Model Mapping

Feature Distribution

Change over Time